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Abstract Despite the large number of studies that have
investigated the use of wearable sensors to detect gait
disturbances such as Freezing of gait (FOG) and falls, there
is little consensus regarding appropriate methodologies for
how to optimally apply such devices. Here, an overview of
the use of wearable systems to assess FOG and falls in
Parkinson’s disease (PD) and validation performance is
presented. A systematic search in the PubMed and Web of
Science databases was performed using a group of concept
key words. The final search was performed in January
2017, and articles were selected based upon a set of eli-
gibility criteria. In total, 27 articles were selected. Of those,
23 related to FOG and 4 to falls. FOG studies were per-
formed in either laboratory or home settings, with sample
sizes ranging from 1 PD up to 48 PD presenting Hoehn and
Yahr stage from 2 to 4. The shin was the most common
sensor location and accelerometer was the most frequently
used sensor type. Validity measures ranged from 73–100%
for sensitivity and 67–100% for specificity. Falls and fall
risk studies were all home-based, including samples sizes
of 1 PD up to 107 PD, mostly using one sensor containing
accelerometers, worn at various body locations. Despite the
promising validation initiatives reported in these studies,
they were all performed in relatively small sample sizes,
and there was a significant variability in outcomes mea-
sured and results reported. Given these limitations, the
validation of sensor-derived assessments of PD features
would benefit from more focused research efforts,
increased collaboration among researchers, aligning data
collection protocols, and sharing data sets.
Keywords Parkinson’s disease  Ambulatory monitoring 
Wearable sensors  Validation studies
Introduction
Parkinson’s disease (PD) is a progressive neurodegenera-
tive disease characterized by four major motor signs: rest
tremor, rigidity, bradykinesia, and postural instability [1].
Non-motor impairments, including executive dysfunctions,
memory disturbances, and reduced ability to smell, are also
seen in the disease [2–4]. Gait difficulties and balance
issues are a disabling problem in many patients with PD,
with different contributing factors, such as freezing of gait
(FOG), festination, shuffling steps, and a progressive loss
of postural reflexes. Its importance is underlined by a high
prevalence of fall incidents in PD, especially in the later
stages of the disease [5–7].
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FOG is defined as a sudden and brief episode of inability
to produce effective forward stepping [8]. The phenomenon
is closely related to falls, appearing mainly during gait ini-
tiation, turning while performing a concomitant concurrent
activity (i.e., dual tasks), or approaching narrow spaces
[9–13]. Similar to FOG, fall episodes occur mainly during a
half-turn or while dual tasking [6]. With disease progression,
the increase of FOG and falling episodes, as well as the
decrease in effectiveness of dopaminergic therapy amplify
the burden related to these symptoms [6, 12, 14].
The management of gait disturbances, such as FOG and
falls, often includes pharmacological interventions [12].
However, there is a growing interest in non-pharmacolog-
ical interventions, such as physiotherapy [15], deep brain
stimulation [16], or cueing devices [17, 18]. In all cases,
reliable tools are required to determine the severity of gait
disorders and evaluate the efficacy of interventions [5].
A number of subjective rating scales are used to evaluate
motor symptoms, but most of them have limited validity and
reliability [19]. To overcome these limitations, wearable
sensors are emerging as new tools to objectively and con-
tinuously obtain information about patients’ motor symp-
toms [20–22]. These sensors, typically consisting of
embedded accelerometers, gyroscopes and other, have been
used to determine PD-related symptoms, including gait
disorders [17, 18, 23–28]. They can act as an extension of
health-professionals’ evaluation of PD symptoms, improv-
ing treatment, and augmenting self-management [29, 30].
Despite a large number of studies that investigated the use of
wearable sensors to detect gait disturbances, such as FOG and
falls, there is little agreement regarding the most effective
system design, e.g., type of sensors, number of sensors, location
of the sensors on the body, and signal processing algorithms.
Here, we provide an overview of the use of wearable systems to
assess FOG and falls in PD, with emphasis on device setup and
results from validation procedures.
Review methodology
A systematic search in the PubMed and Web of Science
databases was performed in accordance with the PRISMA
statement [31]. These databases were chosen to allow both
medical and engineering journals to be included in the
search process.
The search query, based on the PICO strategy [31],
included Parkinson’s disease representing the Population,
wearable, sensors, device representing the Intervention and
falls or freezing of gait representing the Comparison.
Outcome was not included as a key word to keep the query
broad. The truncation symbol (*) and title/abstract filter
were used to both broaden the search and provide more
specificity. The final search query is shown in Table 1.
The final search was performed in January 2017. In
addition to the database search, a search in the references
of review articles and book chapters that appeared during
the search was performed. The goal was to identify
potentially eligible articles absent in the database search.
Articles were selected based upon a set of eligibility cri-
teria. As the objective of this review was to provide an
overview of articles published on the topic, selection criteria
were kept broad. Therefore, studies were included if they (1)
present original research on the validation of wearable sen-
sors (i.e., a single or combination of body worn computer/
sensor [32, 33]) to detect, measure or monitor FOG, falls, or
fall risk and (2) were performed in Parkinson’s disease
patients. Studies were excluded if they (1) only used wear-
ables to deliver cueing for FOG, (2) were published in lan-
guages other than English, or (3) did not provide sufficient
information about study design and results.
Data extraction was performed using a predefined table.
Variables extracted included: author, sample size, device
usage (i.e., type of sensor, number of sensors, and location
of the device), data collection procedures, and validation
results. Validity was considered as the extent to which an
instrument is measuring a concept that it is supposed to
measure. It can be further divided into different types of
validity, such as criterion-referenced validity, construct
validity and content validity. In the case of wearable sen-
sors, researchers are often interested in criterion-referenced
validity, which can be assessed by the correlation between
the sensor-derived outcome and the outcome of a reference
instrument that has already been validated [34, 35]. Con-
struct validity, also known as discriminant validity, is
commonly used by assessing the extent to which groups
that are supposed to produce different outcomes, indeed do
so, for example, by comparing PD with non-PD, or DBS
ON with DBS OFF.
Results
Selection process
In total, 552 articles were retrieved by the query. The
selection process led to the final inclusion of 27 articles. Of
those, 23 articles related to FOG, and 4 to falls. A complete
overview of the selection process is presented in Fig. 1.
Methodologies
FOG detection
A total of 23 articles investigated the use of wearable
sensors to assess FOG in PD [18, 28, 36–56] (Table 2). The
sample sizes varied from 1 [28] to 48 PD [51] per study,
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with a non-PD group being included in a few studies
[28, 40, 48, 51, 53, 56]. Disease severity, when reported,
ranged from 2 to 4 according to the Hoehn and Yahr scale.
Data were collected according to three types of protocols:
(1) a set of structured tasks performed in a laboratory
environment (n = 18); (2) a protocol performed in a lab-
oratory environment in which at least a part of which was
designed to capture naturalistic behaviour (n = 2); and (3)
natural or naturalistic behaviour in a home environment
(n = 3).
The types of sensors embedded in the devices worn by
the participants varied. Tri-axial accelerometers were used
in 22 articles, either as a single sensor (48%, n = 11), or
combined with gyroscopes (35%, n = 8), or magnetome-
ters (13%, n = 3). One study used electroencephalogram to
measure changes in the brain activity from pre-determined
areas during FOG episodes. Regarding the number of body
locations, 56% (n = 13) of the studies utilized one loca-
tion, while the other 44% (n = 10) used a combination of
two or more locations. The shin (66% of studies, n = 16; 4
times used as the single location) and waist (33% of
studies, n = 8; 3 times as the single location) were the
most common body locations for the devices, although nine
other locations were also explored (Fig. 2).
Falls: detection and fall risk analysis
Four articles on falls were retrieved: one article on fall
detection and three articles presented the use of wearable
sensors for analyzing fall risk. All protocols were per-
formed in a home-based setting (Table 3) [57–60], and the
sample size varied from one patient in a case report [57] up
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Table 1 Search queries used for each database
Database Query Hits
Web of
science
(((TI = (sensor*) OR TS = (sensor*) OR TI = (device*) OR TS = (device*) OR TS = (wearable*) OR
TI = (wearable*)) AND (TS = (freezing*) OR TI = (freezing*) OR TI = (fall*) OR TS = (fall*)) AND
(TI = (Parkinson’s*) OR TS = (Parkinson’s*))))
272
PubMed ((‘‘Freezing of gait’’ [tiab] OR Freezing* [tiab] OR fall* [tiab]) AND (wearable* [tiab] OR sensor* [tiab] OR device*
[tiab]) AND Parkinson* [tiab])
280
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Table 2 Characteristics of studies that investigated wearable sensors for FOG detection (n = 23)
Authors Sample Device
locations (n)
Type of sensor Procedures ON OFF References Validity results Tested
for
cueing
FOG detection at home
Martı´n [36] 6 PD FOG? Waist (1) Accelerometer 4 Different
activities: (1)
showing the
home, (2) a
FOG
provocation
test, (3) a
short walk
outdoors and
(4) walking
with a dual
task activity.
Also: a false
positive
protocol
4 4 Labeled video Sensitivity: 91.7%
Specificity: 87.4%
–
Ahlrichs [37] 8 PD
FOG? 12
PD FOG-
Waist (1) Accelerometer Scripted
activities
simulating
natural
behaviour at
the patients’
homes
4 4 Labeled video Sensitivity: 92.3%
Specificity: 100%
–
Tzallas [38] Lab 24 PD
FOG
unknown
Home 12 PD
FOG
unknown
Wrist (2)
Shin (2)
Waist (1)
Accelerometer
Gyroscope
Lab A series of
tasks
Home 5
consecutive
days of free
living
4 4 Lab Live
annotation
by clinician,
confirmed
by video
analysis
Home Self-
reports (no
further
details
provided)
Lab
Accuracy 79%
(sensitivity and
specificity not
reported)
Home Mean
absolute error:
0.79 (no further
explanation
provided;
accuracy,
sensitivity and
specificity not
reported)
–
FOG detection at the laboratory (‘‘free’’ elements included in protocol)
Mazilu [39] 5 PD FOG? Shin (2) Accelerometer
Gyroscope
Magnetometer
3 Sessions on 3
different days
(2 consisting
of walking
tasks, 1 ‘‘free’’
walking in
hospital and
park)
? ? Labeled video Sensitivity: 97%
Specificity: not
reported (only
reported: false
positives count:
27 vs. 99 true
positives)
4
Cole [40] 10 PD FOG
unknown
2 non-PD
Forearm
ACC (1)
Thigh
ACC (1)
Shin ACC
& EMG
(1)
Accelerometer
EMG
Unscripted and
unconstrained
activities of
daily living in
apartment-like
setting
? ? Labeled video Sensitivity: 82.9%
Specificity: 97.3%
–
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Table 2 continued
Authors Sample Device
locations (n)
Type of sensor Procedures ON OFF References Validity results Tested
for
cueing
FOG detection at the laboratory (only tasks)
Rezvanian
[41]
Same as
used in
[17]
Shin (1)
Thigh (1)
Lower back
(1)
Accelerometer Same as used in
[2]
4 4 Same as used
in [2]
Sensitivity/
specificity
Shin only: 84.9/
81%
Thigh only: 73.6/
79.6%
Lower back only:
83.5/67.2%
–
Zach [42] 23 PD
FOG?
Waist (1) Accelerometer A series of
walking tasks
– 4 Labeled video Sensitivity: 78%
Specificity: 76%
–
Kim [43] 15 PD
FOG?
Waist (1)
Trouser
pocket (1)
Shin (1)
Accelerometer
Gyroscope
walking task
(with single
and dual
tasking)
? ? Labeled
video.
Sensitivity/
specificity
Waist only:
86/92%
Trouser pocket
only: 84/92%
Shin only: 81/91%
–
Coste [44] 4 PD FOG
unknown
Shin (1) Accelerometer
Gyroscope
Magnetometer
Walking task
with dual
tasking
? ? Labeled video Sensitivity: 79.5%
Specificity: not
reported (only
number of falls
positives: 13 vs.
35 true positives)
–
Kwon [45] 12 PD
FOG?
Shoe (2) Accelerometer A walking task 4 – Labeled video Sensitivity: 86%
(from graph)
Specificity: 86%
(from graph)
–
Yungher [46] 14 PD
FOG?
Lower back
(1)
Thigh (2)
Shin (2)
Feet (2)
Accelerometer
Gyroscope
Magnetometer
TUG in a 5-m
course.
– 4 Labeled video No validity/
reliability
measures were
reported
–
Djuric-Jovici
[47]
12 PD FOG
unknown
Shin (1) Accelerometer
Gyroscope
To walk along a
complex
pathway,
created to
provoke
freezing
episodes
– 4 Labeled video Sensitivity/
specificity
FOG with tremor:
100/99%
FOG with
complete motor
block: 100/100%
–
Tripoliti [48] 11 PD
FOG? 5
non-PD
Wrist (2)
Shin (2)
Waist (1)
Chest (1)
Accelerometer
Gyroscope
A series of
walking tasks
4 4 Live
annotation
by clinician,
confirmed
by video
analysis
Sensitivity: 81.94%
Specificity: 98.74%
–
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Table 2 continued
Authors Sample Device
locations (n)
Type of sensor Procedures ON OFF References Validity results Tested
for
cueing
Moore [49] 25 PD
FOG?
Lower back
(1)
Thigh (2)
Shin (2)
Feet (2)
Accelerometer TUG on a
standardized
5-m course
– 4 Labeled video ICC number of
FOG/ICC percent
time frozen/
sensitivity/
specificity
All sensors: 0.75/
0.80/84.3/78.4%
1 shin only: 0.75/
0.73/86.2/66.7%
Lower back only:
0.63/0.49/86.8/
82.4%
–
Morris [50] 10 PD
FOG?
Shin (2) Accelerometer TUG on a
standardized
5-m course
– 4 Labeled video ICC for number of
FOG episodes:
0.78
ICC for percentage
time frozen: 0.93
–
Mancini [51] 21 PD
FOG? 27
PD FOG-
21 non-PD
Lower back
(1)
Shin (2)
Accelerometer
Gyroscope
3 Times the
extended
length iTUG
– 4 FOG scale
and ABC
scale, and
comparison
between
groups (PD
FOG?, PD
FOG- and
non-PD)
Criterion validity
Frequency ratio
and FOG scale:
p = 0.6,
p = 0.002
Frequency Ratio
and ABC scale:
p = -0.47,
p = 0.02
Discriminant
validity
Frequency ratio
was larger in PD
FOG? compared
to PD FOG-
(p = 0.001), and
in PD FOG-
versus non-PD
(p = 0.007)
–
Niazmand
[52]
6 PD FOG? Thigh (2)
Shin (2)
Bellybutton
(1)
(sensors
embedded
in pants)
Accelerometer A series of
walking tasks
? ? Labeled video Sensitivity: 88.3%
Specificity: 85.3%
–
Bachlin [17] 10 PD
FOG?
Shin (1) Accelerometer A series of
walking tasks
4 4 Labeled video Sensitivity: 73.1%
Specificity: 81.6%
4
Jovanov [28] 1 PD FOG
unknown
4 non-PD
Knee (1) Accelerometer
Gyroscope
Walking task. ? ? Labeled video No validity
measures were
reported
4
Moore [53] 11 PD
FOG? 10
non-PD
Shin (1) Accelerometer Walking task
along complex
pathway to
provoke FOG
4 4 Labeled video Sensitivity without
calibration: 78%
Sensitivity with
calibration: 89%
Specificity not
reported
–
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to 107 PD in a cross-sectional study [59]. One study
reported disease severity and had an average Hoehn and
Yahr score of 2.6 ± 0.7 [59]. All studies used tri-axial
accelerometers. One study combined this sensor with force
and bending sensors [58]; another with gyroscopes [60].
Sensor body locations included chest, insole (i.e., under the
arch of the foot), and lower back.
Validation
FOG detection
Among the 23 articles investigating FOG detection, 18
reported measures of validation performance (e.g., sensi-
tivity, specificity, or accuracy) [17, 36–45, 47–49, 52–55],
three studies used correlation measures, correlating the
wearable-derived measure with the period of freezing or
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Fig. 2 Distribution of device body location for FOG measurement
Table 2 continued
Authors Sample Device
locations (n)
Type of sensor Procedures ON OFF References Validity results Tested
for
cueing
Mancini [56] 16 PD
FOG? 12
PD FOG-
14 non-PD
Shin (2)
Waist (1)
Accelerometer
Gyroscope
TUG on a 7-m
course
Turning 360 in
place for
2 min
– 4 Labeled video Criterion validity
Freezing ratio
duration 9
clinical ratings:
p = 0.7,
p = 0.003
Freezing Ratio
duration 9 FOG
questionnaire:
p = 0.5, p = 0.03
–
Capecci [55] 20 PD
FOG?
Waist (1) Accelerometer TUG on a
standardized
5-m course
4 – Labeled video Algorithm
1/Algorithm 2
Sensitivity: 70.2/
87.5%
Specificity: 84.1/
94.9%
Precision: 63.4/
69.5%
Accuracy: 81.6/
84.3%
AUC: 0.81/0.90
–
Handojoseno
[54]
4 PD FOG? Scalp (8) EEG TUG on a
standardized
5-m course
4 – Labeled video Sensitivity occipital
channel: 74.6%
Specificity occipital
channel: 48.4%
Accuracy occipital
channel: 68.6%
–
FOG freezing of gait, PD Parkinson’s disease, FOG? PD patients with diagnosed freezing of gait events, FOG: PD patients with no diagnosed
freezing of gait events, SC skin conductivity, ECG electrocardiogram, non-PD participants that have not been diagnosed with PDm ACC three tri-
axial accelerometer, TUG timed-up-and-go test, ICC Intraclass correlation, iTUG automated timed-up-and-go test, FOG questionnaire freezing
of gait questionnaire, ABC scale the activities-specific balance confidence scale, AUC area under curve
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Table 3 Characteristics of studies that investigated wearable sensors for fall and fall risk (n = 4)
Authors Sample Device
location
(n)
Type of sensor Measure(s) Procedures ON OFF References Validity results
Fall detection at home
Tamura
[57]
1 PD Chest
(1)
Accelerometer Detection of
falls
Participant
carried the
sensor in daily
life
4 4 Fall diary Criterion validity
19 out of 22 falls
were detected.
Specificity/false
positives not
reported
Fall risk at home
Ayena
[58]
7 PD
12 Young
non-PD
10
Elderly
non-PD
Insole
(4)
Accelerometer
Force sensor
Bending
sensor
Proposed new
OLST score
(with
incorporation
of both
iOLST and
score derived
from balance
model)
Participants
performed the
OLST at home
as part of a
serious game
for balance
training
4 – iOLST score
Comparison
between
groups (PD
vs young
non-PD vs
elderly non-
PD, ground
type)
Criterion validity:
Proposed OLST score
was not
significantly
different from
iOLST score in all
groups
Discriminant validity
- Proposed OLST
score was
significantly
different between
PD and non-PD
subjects
- Proposed OLST
score was
significantly
differed between
ground types
Weiss
[59]
107 PD Lower
back
(1)
Accelerometer Anterior-
posterior
width of
dominant
frequency
Patients wore the
sensor for 3
consecutive
days at home
4 4 Comparison
with BBT,
DGI and
TUG
Among non-
fallers: time
until 1st fall
during
1-year
follow-up
Comparison
between
fallers
(n = 40)
and non-
fallers
(n = 67)
based on fall
history
Criterion validity
Anterior-posterior
width was
significantly
correlated with
BBT (r = -0.30),
DGI (r = -0.25)
and TUG
(r = 0.32)
Among non-fallers:
anterior-posterior
width significantly
associated with time
until 1st fall
(p = 0.0039, Cox
regression corrected
for covariates)
Discriminant validity
Anterior-posterior
width was larger
(p = 0.012) in the
fallers compared to
the non-fallers
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number of FOG events [50, 51, 56], and two studies did not
report validity measures [28, 46].
Overall, validity values ranged from 73 to 100% for
sensitivity, and from 67 to 100% for specificity, and
accuracy ranged from 68% up to 96%. Validity measures
are summarized and compared across protocol setups in
Figs. 3 and 4.
Fall detection and fall risk analysis
One article investigated the use of wearable sensors to
detect falls, by comparing the data from a self-reported
diary to the sensor data. The sensor captured 19 fall events
from a total of 22 self-reported events [57].
Three articles presented the use of wearable sensors for
analyzing fall risk. All of them reported discriminant
validity by comparing sensor-derived outcomes between
different groups, such as fallers and non-fallers or PD
versus non-PD (see Table 3 for details). Weiss et al. [59]
reported an illustrative approach, whereby the 107 partic-
ipating PD patients wore one sensor in the lower back and
made diary annotations about fall events. The sensor data,
collected remotely in the patient’s home, were subse-
quently used to calculate a fall risk index. The time until
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Table 3 continued
Authors Sample Device
location
(n)
Type of sensor Measure(s) Procedures ON OFF References Validity results
Iluz
[60]
40 PD Lower
back
(1)
Accelerometer
Gyroscopes
Detection of
missteps
Laboratory
Walking tasks
designed to
provoke
missteps
(including dual
tasking and
negotiating
with obstacles)
Home
Participants
worn the
devices for 3
days during
day time
4 4 Laboratory
Notation by
clinicians
Labeled video
Home
Comparison
of groups
(fallers vs.
non-fallers)
Criterion validity
Laboratory:
Hit ratio: 93.1%
Specificity: 98.6%
Discriminant validity
Home:
Odds ratio of
detection 1 or more
missteps in fallers
vs non-fallers: 1.84
(p = 0.010, 95%
confidence interval
1.15–2.93)
PD Parkinson’s disease patients, OLST one-leg standing test, iOLST automatic one-leg standing test, BBT Berg balance test, DGI dynamic gait
index, TUG, timed-up-and-go
1650 J Neurol (2017) 264:1642–1654
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first fall was significantly lower in subjects with a higher
variable gait pattern (log rank test: p = 0.0018, Wilcoxon
test: p = 0.0014).
Discussion
This review included 27 articles, 23 on FOG, and four on
falls. FOG studies were performed either in a laboratory or
at home, with different types of protocols (structured ver-
sus free-movement). The shin (16/28 studies) was the most
common device location and tri-axial accelerometers (26/
28 studies) the most common sensor type. Sensitivity
ranged from 73% to 100% and specificity ranged from 67%
to 100% for the detection of FOG. Fall and fall risk studies
were all home-based, using mostly one device (3/4 studies)
containing tri-axial accelerometers. Sensors were posi-
tioned on the chest, insole, and lower back. The systems
detected falls or quantified fall risk by various approaches
and with varying degrees of validity.
FOG detection
The results in this review support the potential for wearable
devices. In the laboratory, systems showed a moderate to
high specificity and sensitivity, which are in line with other
evidence that wearable systems detecting FOG are already
well validated in a laboratory setting [30]. Moreover,
promising results were also achieved in studies performed
in the home environment. Interestingly, the comparison of
validity measures in terms of sensitivity and specificity
(Figs. 3, 4) suggests that wearable sensors are able to
accurately detect FOG, independent of study protocol (e.g.,
home versus laboratory environment; structured versus
unstructured protocols) and system design (e.g., one sensor
only versus multiple sensors, and one device versus a set of
combined devices in different body locations). However,
one should be cautious when directly comparing reported
performance between studies, for a number of reasons: in
particular, one should consider additional factors, such as
algorithm used, outcome definitions, data analysis meth-
ods, and the intended application of the system.
First, even though FOG is a well-defined symptom [8],
what objectively constitutes FOG is unclear. The challenge
lies in rigorously defining, from an algorithmic point of
view, such a complex event, which can appear in different
forms and intensities. Furthermore, the definition of the
measured outcome has an important impact upon instru-
ment validity assessment. In this review, some studies only
included long-duration FOG episodes. Omitting small FOG
episodes may lead to inaccurate estimates of FOG detec-
tion rates. A comprehensive definition such as that used by
Djuric–Jovici and colleagues [47], differentiating between
FOG with trembling and FOG with complete motor blocks
prior to video labeling and test properties, seems to address
the problem by incorporating different types of FOG
events. However, this definition was not used in other
studies. A clear and comprehensive definition would
improve the comparability of instrument performance.
Second, the intended application of the instrument is
another aspect to be considered in FOG detection. It is
attractive to aim for rates of 100% specificity and sensi-
tivity. However, this may result in signal processing
operations which require substantial computational
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resources. As illustrated by Ahlrichs [37], the detection of
FOG episodes was achieved with high sensitivity and
specificity, but the data processing was time-consuming
with delays of up to 60 s. Similarly, algorithms with high
accuracy may require substantial computational resources
which may have an adverse effect on power consumption
and hence battery life for non-intrusive, portable devices.
This fact may prevent the use of such systems for real-time
detection and cueing. Therefore, it is reasonable to con-
clude that at this point, the acceptability of instrument
performance in detection of FOG relate to its application,
and many of these algorithms will require substantial
mathematical and engineering efforts in order to reduce
computational delays to an acceptable level. Furthermore,
some algorithms required individual calibration and others
did not, which also has practical consequences for appli-
cations in clinical and research practice.
Finally, although there exists the potential for these
instruments being applied to long-term monitoring in free
living conditions, only a few systems were actually vali-
dated in the home environment. Therefore, the majority of
the technology available lacks ‘‘ecological’’ validation.
Thus, further research using larger sample sizes, longer
follow-up periods under more realistic home environments
is necessary.
Fall detection and fall risk calculation
Del Din and colleagues described that real-world detection
of falls is a substantial challenge from a technical per-
spective, and almost all evidence in their review was lim-
ited to controlled settings and young healthy adults [30].
This finding is confirmed in this review, most clearly
illustrated by the fact that we only found one article
reporting on fall detection accuracy in PD. However, it is
possible that this small number of articles is not only a
result of the complexity of capturing falls in PD under
realistic, free-living conditions. It certainly highlights an
area where the validity of wearable sensors still needs to be
examined. In addition, fall risk calculation has the potential
to provide objective information before the fall event
happens, which may be more valuable than simply count-
ing the number of events and dealing with the
consequences.
Fall risk estimation has a clear relevance for clinical
practice [58]. Falls are common and disabling, even in
early PD [61]. In addition, falls are also related to physical
injury [61], high hospitalization cost [62], and social/psy-
chological impact [63], either on their own or due to the
anticipatory fear of falling [64]. Even though the number of
retrieved articles investigating fall risk calculation was not
high, the results seem to confirm the potential for wearable
sensors to accurately calculate fall risk for PD.
Conclusion
This systematic review presents an overview of studies
investigating the use of wearable sensors for FOG and falls
in Parkinson’s disease. Despite promising validation ini-
tiatives, study sample sizes are relatively small, partici-
pants are mainly in early stages of the disease, protocols
are largely laboratory-based, and there is little consensus
on algorithms analysis. Further work in ecological valida-
tion, in free-living situations, is necessary. There also is a
lack of consistency in outcomes measured, methods of
assessing validity, and reported results. Given these limi-
tations, the validation of sensor-derived assessments of PD
features would benefit from increased collaboration among
researchers, aligning data collection protocols, and sharing
data sets.
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